Noticing Blood in Your Urine While Taking Mounjaro

You notice something in the toilet and the Mounjaro pen is in the fridge door

It is a jarring moment. You have been a few weeks into treatment, perhaps managing some nausea, and now there is a pink or red tinge in the toilet bowl. The first thing worth knowing is that Mounjaro itself is not a recognised cause of blood in the urine. The published NHS guidance on tirzepatide and the medicine's Summary of Product Characteristics list the established side effects clearly, and haematuria does not appear among them. That does not make the symptom trivial. It means the cause is likely something separate from the medication and needs its own investigation.

Haematuria in the general population most often traces back to urinary tract infections, kidney stones, bladder irritation or, less commonly, conditions affecting the kidneys or bladder that require proper diagnosis. None of those possibilities disappear just because someone has started a weight-loss injection. If you can see blood with the naked eye, contact NHS 111 or your GP today. Do not wait to see whether it resolves on its own.

Can tirzepatide affect the kidneys in a way that might reach the urine?

This is the question most people are actually asking when they search whether Mounjaro can cause blood in urine. The honest answer is nuanced. Tirzepatide as a molecule does not directly damage kidney tissue in the way some medicines can. In fact, early research on GLP-1 receptor agonists has explored potential protective effects on kidney function, though the evidence in humans is still developing and no such claim is made in current UK labelling.

The indirect link worth understanding is dehydration. Mounjaro commonly causes nausea, vomiting and diarrhoea, particularly in the first weeks or after a dose increase. Significant fluid loss can concentrate urine, reduce kidney perfusion and, in susceptible people, cause kidney function to dip temporarily. Dehydration-related kidney strain does not typically produce visible blood, but it can alter urinary output and colour. If you have had severe GI symptoms and are not keeping fluids down, that alone is a reason to contact a clinician. You can read more about how Mounjaro affects the broader picture of urinary changes on our overview of Mounjaro and urine changes.

It is also worth knowing that tirzepatide carries a Black Triangle designation from the MHRA, meaning all suspected side effects should be reported. If you think your symptom could be related to the medicine, submit a Yellow Card report alongside seeking clinical help. The report does not replace treatment, but it contributes to ongoing safety monitoring.

What to tell your doctor and what they will likely check

When you contact a GP or urgent care service, give them the full picture: when you first noticed it, whether it is visible blood or was only picked up on a dipstick test, any pain or discomfort (particularly in the lower back or side, which can point to the kidney or ureter), any recent urinary symptoms like burning or frequency, and how long you have been on Mounjaro and at which dose. The prescriber who manages your weight-loss treatment will also want to know, since any significant new symptom is relevant to the clinical review that should precede each repeat prescription.

A GP is likely to request a urine dipstick and midstream sample, and may check kidney function through a blood test. If the cause is something like a UTI, treatment is straightforward and there is usually no reason to stop Mounjaro. If kidney function is genuinely impaired, a prescriber may recommend pausing treatment while the cause is identified, since tirzepatide is not recommended in severe renal impairment under current guidance. There are separate kidney-function considerations explored on our page about blood tests associated with Mounjaro treatment.

Some patients also wonder whether blood elsewhere in the GI tract could be creating confusion. Frank blood in stool is a separate symptom to watch for; if you are uncertain which is happening, a clinician can help clarify quickly. Our page on Mounjaro and blood in stool covers that scenario.

Continuing treatment safely after a urinary symptom

Most people who experience haematuria while on a weight-loss medicine will find a straightforward cause, receive treatment, and continue their programme without interruption. A UTI clears with antibiotics; a kidney stone typically passes. The important habit is not to dismiss new symptoms as medication side effects until that has actually been established by someone qualified to assess you.

If you are on Mounjaro through a private provider and are unsure how to reach your prescriber, that is worth sorting out now rather than during a health scare. The clinical team at nume is available for aftercare support seven days a week, and every repeat prescription involves a clinical review so that symptoms like this can be flagged and addressed properly. For a broader look at how tirzepatide works and what monitoring is appropriate during treatment, including questions about whether cagrilintide can be taken alongside tirzepatide, the tirzepatide overview is a useful reference. The MHRA's public guidance on GLP-1 medicines for weight loss also covers what to watch for during treatment.

Changes in urine colour or smell that are less urgent than visible blood are worth understanding too. Our pages on urine colour changes on Mounjaro and urine smell changes on Mounjaro answer those specific questions. If you are considering starting treatment or have questions about clinical suitability, you can check your eligibility through a free consultation.